You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Saudi Arabia

Nov 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Growing confidence in self-medication drives growth

Consumer health saw strong growth for the review period as a whole, with this linked to consumers’ growing confidence in self-medication. Consumers began to take an increasingly proactive approach to their health, with this trend encouraged by a stronger media and government focus on health issues. Consumers also began to feel more confident in approaching pharmacists for advice regarding potentially embarrassing health conditions, thanks to the wider provision of female pharmacists and private consulting rooms at chemists/pharmacies.

Rising economic confidence fuels growth in 2011

There was growing economic confidence in Saudi Arabia in 2011, as the impact of the 2009 economic slowdown began to recede. In addition, consumers benefited from the introduction of a SR3,000 per month minimum wage, which increased low-income consumers’ ability to afford a wider range of consumer health. Consequently, most product areas saw a stronger current value performance in 2011 in comparison to that seen in the previous year.

Multinationals dominate but SPIMACO leads

Multinationals continued to dominate sales of consumer health at the end of the review period. Many consumers regard these players as offering higher quality products, with players such as GlaxoSmithKline also benefiting from strong marketing support. The leading player however continued to be domestic company Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO). This player enjoys a strong appeal thanks to offering a wide range of its own branded generics and also offering global brands produced under license such as Merck’s Claritine.

Chemists/pharmacies continue to dominate but distribution widens

Chemists/pharmacies continued to dominate sales of consumer health at the end of the review period. This is chiefly due to strict government controls over distribution, with many products only permitted for sale via chemists/pharmacies. Distribution continued to widen at the end of the review period, however, with kiosks proving increasingly successful within “other” grocery and non-grocery retailers.

Stronger growth ahead for forecast period

The forecast period is expected to see a stronger constant value growth in comparison to that seen during the review period. Stronger growth will be linked to consumers’ growing focus on health and wellness. An increasingly proactive approach to health is for example likely to support strong growth in vitamins and dietary supplements and weight management. Meanwhile OTC is expected to benefit from growing confidence in self-medication, which will in turn be bolstered by advertising for the leading brands. Rising disposable income levels are also expected to support stronger sales growth during the forecast period.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Saudi Arabia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Saudi Arabia, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Saudi Arabia for free:

The Consumer Health in Saudi Arabia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Saudi Arabia?
  • What are the major brands in Saudi Arabia?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Saudi Arabia - Industry Overview

EXECUTIVE SUMMARY

Growing confidence in self-medication drives growth

Rising economic confidence fuels growth in 2011

Multinationals dominate but SPIMACO leads

Chemists/pharmacies continue to dominate but distribution widens

Stronger growth ahead for forecast period

KEY TRENDS AND DEVELOPMENTS

Greater economic confidence fuels growth in 2011

Increasingly proactive consumer approach to health boosts sales

High birth rate shapes growth

Stressful lifestyles boost demand for fast-acting and convenient products

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

SOURCES

  • Summary 1 Research Sources

Consumer Health in Saudi Arabia - Company Profiles

Jamjoom Pharma in Consumer Health (Saudi Arabia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Jamjoom Pharma: Competitive Position 2011

Riyadh Pharma Medical & Cosmetic Products Co Ltd in Consumer Health (Saudi Arabia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Riyadh Pharma Medical & Cosmetic Products Co Ltd: Competitive Position 2011

Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO) in Consumer Health (Saudi Arabia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO): Competitive Position 2011

Tabuk Pharmaceutical Mfg Co in Consumer Health (Saudi Arabia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Tabuk Pharmaceutical Mfg Co: Competitive Position 2011

Adult Mouth Care in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care continued to benefit at the end of the review period from a widening range of products becoming available during the review period. 2008 for example saw the introduction of affordable domestic brand Piodin by Tabuk, while herbal/traditional products also saw strong development during the review period. Optima was a pioneer in this area with the launch of Aloedent in 2009, with Zinopharma’s Zino Den-Sept also emerging in herbal/traditional products in the year. New product development consequently offered consumers a wider choice in adult mouth care during the review period. Sales also benefited from stronger advertising in the second half of the review period, both from new entrants and established leaders such as SPIMACO’s Orasept with this boosting consumers’ awareness of these products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO) was the clear leader in adult mouth care in 2011 and accounted for 35% value share. This company benefits from offering a wide range of affordable branded generics. Its strongest brand is Orasept Mouth Wash, which accounted for 19% value share in 2011, while the company’s Betadine Mouth Wash, Chlorasept and Florasept accounted for 5-6% value share each. The company however lost share during the review period and dropped by over half a percentage point in 2011 over the previous year due to growing competition.

PROSPECTS

  • There is expected to be ongoing steady growth for adult mouth care during the forecast period, with a slightly stronger constant value growth in comparison to the review period at 3% CAGR. Growth will be supported by widening consumer awareness, which will in turn be encouraged by players investing in marketing support directed to both consumers and pharmacists. This product area saw growing competition towards the end of the review period, with players continuing to jostle for share during the forecast period by pushing for wider distribution and awareness.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 14 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • While Saudi Arabia has a strong legislative framework for the classification of OTC and Rx medicines, UTC sales of Rx medicines are widely available. If a consumer requests a brand of Rx analgesics by name, they will generally be able to obtain these products without a description. Word-of-mouth recommendations encouraged many consumers to switch from OTC to Rx analgesics, while others continued to take Rx products following an initial prescription from doctors. This trend particularly hit ketoprofen and diclofenac, with a switch to higher-potency Rx variants resulting in 2% and 1% volume sales decline respectively in these product areas in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • SPIMACO was the clear leader in analgesics in 2011, accounting for a strong 28% value share. This company benefits from offering a wide range of products and prices and also from its strong distribution network. The company offers a wide range of branded generics such as Rofenac, which are available at affordable prices and have a strong reputation for quality. In addition, the company also offers value-added global brands produced under license such as Bristol-Myers Squibb’s Tempra.

PROSPECTS

  • The Saudi government is likely to continue to adjust its approach to analgesics during the forecast period. There is expected to be growing liberalisation for many product areas and their leading brands in terms of distribution and advertising. This trend is expected to encourage a growing number of consumers to self-medicate within analgesics and is expected to boost the share of well-advertised brands such as GlaxoSmithKline’s Panadol. In addition, this trend is expected to encourage consumers to opt for value-added variants that claim to offer faster action or a longer-lasting effect.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 20 Analgesics Company Shares by Value 2007-2011
  • Table 21 Analgesics Brand Shares by Value 2008-2011
  • Table 22 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • The government did little to prevent UTC sales of Rx medicines in most product areas during the review period, with most chemists/pharmacies selling Rx products on request without a prescription or even recommending these products to customers. However, there was growing concern regarding the misuse of Rx calming and sleeping during the review period, with the government being concerned about the health impact of this trend. Consequently, the government increasingly clamped down upon UTC sales of Rx products during the review period. With Rx medicines becoming less widely available, a growing number of consumers turned to OTC calming and sleeping.

SWITCHES

COMPETITIVE LANDSCAPE

  • Boehringer Ingelheim Pharma continued to be a strong leader in calming and sleeping in 2011, accounting for a steady 45% value share in the year. The company’s Songha Night was introduced in 2007 and swiftly rose to prominence thanks to the company targeting pharmacists and doctors with strong marketing. While Songha Night is priced higher than many of its competitors, it has a strong reputation for efficacy and thus enjoys strong customer loyalty. The brand benefits from strong word-of-mouth recommendations in addition to wide distribution.

PROSPECTS

  • Calming and sleeping is expected to continue to benefit from rising stress in consumers’ lives during the forecast period and from a growing awareness that this stress can be tackled via self-medication. Regional unrest is expected to continue to concern many consumers at the start of the forecast period, as will the potential impact of the global economic downturn. Long working hours, longer commutes and urban overcrowding will all also contribute to higher stress levels. With consumers becoming more confident regarding self-medication, calming and sleeping is thus expected to see a dynamic constant value and volume CAGR of 12% during the forecast period.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2006-2011
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 26 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 27 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Saudi Arabia has a high and rising incidence of allergies. This is linked partly to the numerous sandstorms that hit the country’s cities during autumn and summer. The strong use of air conditioning and high temperatures also contributed to a high incidence of allergies, with most consumers spending the majority of their time indoors in an air conditioned environment. There was a growing focus on allergies during the review period, with more frequent media reports covering ailments such as rhinitis and hay fever, particularly among children. This boosted consumers’ awareness of these products and encouraged growing self-medication. Antihistamines/allergy remedies (systemic) accounted for 22% value share of overall cough, cold and allergy (hay fever) remedies in 2011 and saw above-average current value growth of 13% in the year. Paediatric allergy remedies meanwhile saw an even stronger sales growth from a low base, with a rise of 14%, as consumers became more confident when self-medicating for children.

SWITCHES

COMPETITIVE LANDSCAPE

  • Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO) was the clear leader in cough, cold and allergy (hay fever) remedies throughout the review period and accounted for 18% value share in 2011. SPIMACO benefits from offering a wide range of products and prices, including affordable branded generics such as Flutapp and strong global brands such as Merck’s Claritine and Novartis’ Zaditen. The company dominated paediatric allergy remedies in 2011 with 53% value share and also led sales of antihistamines/allergy remedies (systemic) and overall paediatric cough, cold and allergy (hay fever) remedies. The company also ranked third in combination products and cough remedies in 2011.

PROSPECTS

  • Consumers are expected to show a growing confidence in self-medication within cough, cold and allergy (hay fever) remedies during the forecast period. This will be linked to stronger advertising for leading brands within this area and also to a growing focus on health in general. This trend is expected to particularly benefit antihistamines/allergy remedies (systemic), which is thus set to see 5% constant value CAGR during the forecast period in comparison to 4% CAGR during the review period. There will also be a rising confidence in self-medicating for children, with paediatric cough, cold and allergy (hay fever) remedies thus set to see 6% constant value CAGR during the forecast period in comparison to 3% constant value CAGR during the review period.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 32 Sales of Decongestants by Category: Value 2006-2011
  • Table 33 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 34 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Consumers showed a growing confidence when it came to self-medicating digestive remedies towards the end of the review period. This was partly linked to rising advertising for brands such as GlaxoSmithKline’s Gaviscon in antacids, particularly via regional satellite TV channels. Consumers notably became more willing to self-medicate for their children, supporting 12% current value growth in paediatric digestive remedies in 2011 over the previous year.

SWITCHES

COMPETITIVE LANDSCAPE

  • Julphar Gulf Pharmaceuticals was the leading player in digestive remedies in 2011 with 14% value share, despite losing half a percentage point in share from 2010 and seven percentage points from 2006. The company benefits from offering a wide range of affordable branded generics, such as Moxal in antacids, Rantag in H2 blockers and Scopinal in IBS treatments. The company lost share due to growing competition from a number of different areas. Within antacids, the company for example lost share due to strong competition from GlaxoSmithKline’s well-advertised Gaviscon and due to the widening presence of economy brands. Within H2 blockers, the company also faced competition from small economy brands but also saw current value sales eroded by strong competition from Rx medicines.

PROSPECTS

  • Consumers are expected to have an increasingly indulgent approach to food during the forecast period. Consumer foodservice is expected to continue to rise in popularity, with consumers increasingly dining out with friends and family rather than eating at home. Busier lifestyles will also support strong growth for both consumer foodservice and for meal solutions within packaged food, while also encouraging more indulgent eating habits as consumers seek to recompense for stress. Increased stress and more indulgent eating patterns, coupled with fast and feast periods such as Ramadan, will create a positive environment for sales of digestive remedies during the forecast period. Consumers are expected to increasingly suffer from acid-related digestive problems, ulcers, flatulence, diarrhoea and constipation as a result.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 42 Digestive Remedies Company Shares by Value 2007-2011
  • Table 43 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Ear care continued to be hindered by a small product range at the end of the review period, with Riyadh Pharma Medical & Cosmetic Products’ Ear Calm being the only significant brand. This lack of competition also resulted in a lack of new product development towards the end of the review period. Ear care thus remained a small niche in consumer health at the end of the review period, with sales reaching less than SR2 million.

SWITCHES

COMPETITIVE LANDSCAPE

  • Riyadh Pharma Medical & Cosmetic Products was the sole significant player in ear care at the end of the review period, with this company’s Ear Calm brand accounting for 94% value share in 2011. This domestic brand is the sole brand with a consistent and wide distribution presence in the country. The brand is also popular thanks to offering analgesic benefits, thus reducing ear pain linked to infection or injury.

PROSPECTS

  • Ear care is expected to see a considerably stronger performance during the forecast period, with a volume and constant value CAGR of 4% in comparison to a review period CAGR of 1% in volume and constant value terms. Stronger growth will be linked to widening consumer awareness of this product area. Riyadh Pharma Medical & Cosmetic Products’ marketing aimed at pharmacists and doctors will also drive growth, with these healthcare professionals becoming more aware of Ear Calm’s benefits.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2006-2011
  • Table 47 Sales of Ear Care: % Value Growth 2006-2011
  • Table 48 Ear Care Company Shares by Value 2007-2011
  • Table 49 Ear Care Brand Shares by Value 2008-2011
  • Table 50 Forecast Sales of Ear Care: Value 2011-2016
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2011-2016

Eye Care in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Eye care benefited from consumers spending longer in front of computer and TV screens during the review period, with this trend increasing the incidence of dry and itchy eyes. Many consumers notably worked longer hours on computers, as they sought to further their careers against a backdrop of economic growth. In addition, the rising household penetration of broadband enabled computers and satellite TV encouraged consumers to spend a growing portion of their leisure time sat in front of screens.

SWITCHES

COMPETITIVE LANDSCAPE

  • Eye care is highly consolidated, with three players together accounting for 76% of value sales in 2011. Most consumers tend to be brand loyal when it comes to eye care and are often unwilling to try new brands. Allergan accounted for 32% share in overall eye care in the year, with its Refresh brand accounting for close to 40% of value sales in standard eye care. Alcon meanwhile ranked second with 25% share, with its Naphcon and Tears Naturale brands accounting for 29% value share in allergy eye care and 22% value share in standard eye care respectively. Ciba Vision meanwhile ranked third with 19% value share, with its Viscotears brand accounting for 17% value share in standard eye care.

PROSPECTS

  • Eye care is expected to continue to see strong and steady sales growth during the forecast period, with a volume and constant value CAGR of 6%. These growth rates are in line with those seen during the review period. Growth will continue to be underpinned by a number of long-term trends, among which consumers’ increasing exposure to computer and TV screens is likely to be most significant. Eye care is also expected to continue to benefit from a hot and dusty climate in Saudi Arabia and from the widespread use of 24hr air conditioning. A growing confidence in self-medication will also fuel growth, as will widening consumer awareness of these products and rising disposable income levels for low-income consumers.

CATEGORY DATA

  • Table 52 Sales of Eye Care by Category: Value 2006-2011
  • Table 53 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 54 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 55 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 56 Eye Care Company Shares by Value 2007-2011
  • Table 57 Eye Care Brand Shares by Value 2008-2011
  • Table 58 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 59 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • There was widening consumer awareness of herbal/traditional products during the review period. This was linked to widening distribution for these products via chemists/pharmacies, with pharmacists also becoming more likely to recommend these products thanks to more effective marketing from players in this area. Consumers increasingly regard herbal/traditional products as safe and gentle and also have growing confidence in these products’ efficacy.

COMPETITIVE LANDSCAPE

  • Cadbury Adams and Nattermann led sales of herbal/traditional products at the end of the review period, accounting for 13% and 11% value share respectively in 2011. Cadbury Adams benefits from its strength in medicated confectionery, where the company offers the Halls and Vita-C brands. The company invests heavily in marketing and benefits from wide distribution, with strong advertising resulting in the company gaining a further half a percentage point in value share in 2011 over the previous year. Nattermann meanwhile maintained a steady value share of 11% in the year, with the company’s Bronchicum and Melrosum being paediatric cough/cold remedies with a strong reputation for quality and safety.

PROSPECTS

  • Herbal medicine is expected to see increasing government scrutiny during the forecast period. The MoH announced plans in August 2011 to launch an alternative medicine department, with this overseeing acupuncture and herbal clinics in the country. This may make life more difficult for herbalists, which could result in consumers switching to packaged herbal/traditional products. However, those herbalists that continue to operate are likely to be those focused on registered and packaged products. Consumers are expected to have more trust in these outlets and their recommendations during the forecast period, as lower quality herbalists and unauthorised products exit.

CATEGORY DATA

  • Table 60 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 61 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 62 Herbal/Traditional Products Company Shares 2007-2011
  • Table 63 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 64 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 65 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Consumers became more confident in seeking advice about embarrassing ailments during the review period. While there continue to be considerable social taboos surrounding issues such as vaginal fungal infections, haemorrhoids and lice, there was a growing willing to seek advice on these issues from pharmacists. Women in particular became more likely to seek advice from pharmacists, due to the widening provision of segregated chemists/pharmacies and female pharmacists. Private consulting rooms at many chemists/pharmacies also encouraged this trend. This trend supported strong growth in a number of product areas, with vaginal antifungals and haemorrhoid treatments seeing 11% current value growth each in 2011 and antiparasitics/lice (head and body) treatments seeing 10% growth in the year.

SWITCHES

COMPETITIVE LANDSCAPE

  • Reckitt Benckiser was a clear leader in medicated skin care in 2011 with a value share of 31%. It thus dwarfed its closest competitor Schering-Plough, which accounted for just 5% value share in the year. Reckitt Benckiser also saw a strong rise in value share in the year at over half a percentage point. This strong lead and strong share gain was entirely due to the company owning the dominant brand in topical germicidals/antiseptics, Dettol. Dettol accounted for 62% value share in this dynamic product area in 2011 and continued to gain share marginally over the previous year.

PROSPECTS

  • Growth in medicated skin care will continue to be driven by topical germicidals/antiseptics and by consumers’ growing focus on hygiene and the removal of bacteria. Reckitt Benckiser’s Dettol is expected to be a major force behind this trend, with the brand continuing to advertise heavily and also continuing to participate in hygiene-related consumer education campaigns. Households are thus likely to increasingly use topical germicidals/antiseptics on an everyday basis in order to ensure that their homes are clean and to prevent the spread of bacteria. Topical germicidals/antiseptics is thus expected to see the most dynamic constant value growth during the forecast period at a CAGR of 7% and will account for 56% of overall value sales in medicated skin care by 2016.

CATEGORY DATA

  • Table 66 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 67 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 68 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 69 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 70 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 71 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • The government adopted an increasingly anti-smoking stance during the review period. There were initial attempts to introduce smoking bans in many cities. In addition, the government dramatically increased taxation levels for tobacco products during the review period. In 2011, the government also imposed a smoking ban on the country’s airports, with a SR200 fine for those violating this ban.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Consumer Health was the sole player present in NRT smoking cessation aids during the review period, with its Nicotinell brand accounting for all value sales. Prior to the review period, Pfizer offered Nicorette in NRT gum. However, there were poor sales in this product area due to gum chewing being considered impolite by many Saudis, with Pfizer thus exiting in 2006.

PROSPECTS

  • The forecast period is expected to see an even stronger attack on smoking by the Saudi government. In August 2012, a ban on smoking in most public places came into effect, including government offices, consumer foodservice outlets and retail outlets. This legislation also includes a ban on the smoking of shishas and on the sale of tobacco products to those aged 18-years-old or younger. In July 2012, a Saudi judge meanwhile ruled that women could divorce a smoking husband due to the dangers of passive smoking, while concerns over passive smoking are also expected to impact custody battles in the case of divorce.

CATEGORY INDICATORS

  • Table 72 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 73 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 74 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 75 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 76 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 77 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 78 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition saw volume sales decline in 2011 over the previous year. This was linked to a shift to foreign internet retailing sites for the purchase of protein powder, which accounts for all sales in this product area. This trend was linked to the widening household penetration of broadband enabled computers and a growing willingness to shop online. Consumers increasingly found that purchasing from international sites such as bodybuilding.com enabled them to save money, even factoring in delivery charges, due to high prices for these products in Saudi Arabia. While this trend also benefited domestic internet retailing sites, with internet retailing gaining almost half a percentage point in value share from 2010 to account for 3% share of overall value sales, many opted for cheaper foreign sites. As a result of this trend, protein powder saw 5% volume sales decline in 2011 over the previous year.

COMPETITIVE LANDSCAPE

  • Optimum Nutrition was the dominant player in sports nutrition throughout the review period and accounted for 74% value share in 2011. This company has the widest and most consistent distribution presence and faced little steady competition, with second ranked player General Nutrition being the only other player with significant distribution in the country. General Nutrition accounted for 17% value share in 2011.

PROSPECTS

  • Sports nutrition is expected to benefit from a growing focus on health and wellness in Saudi Arabia during the forecast period. Saudi men are expected to increasingly prize a toned and muscular physique, with this linked to the influence of celebrity culture via the internet and satellite TV. Sports nutrition is meanwhile likely to benefit from this trend, with a growing number of mid- and high-income men either keeping bodybuilding equipment in their home or visiting gyms on a regular basis. As a result, sports nutrition is expected to see a considerably stronger performance during the forecast period with a constant value growth of 15%, up from just 2% growth during the review period.

CATEGORY DATA

  • Table 79 Sales of Sports Nutrition: Value 2006-2011
  • Table 80 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 81 Sports Nutrition Company Shares 2007-2011
  • Table 82 Sports Nutrition Brand Shares 2008-2011
  • Table 83 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 84 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • There was growing health-consciousness in Saudi Arabia during the review period. This trend was partly linked to a growing media focus on health issues, while the Swine Flu epidemic in the middle of the review period also resulted in many consumers striving for greater general health. Consumers also became more aware of the health benefits of the different product areas present in vitamins and dietary supplements. This was not only linked to stronger coverage in traditional media channels such as TV and magazines but also to widening internet access. As a result, consumers increasingly took vitamins and dietary supplements in order to prevent health problems, for example taking Echinacea to boost their immune systems or calcium supplements to prevent osteoporosis.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • General Nutrition Centers was the only player in vitamins and dietary supplements with a double-digit value share in 2011, accounting for 11% share. The company offers an extremely wide range and is the only player with a strong and consistent distribution product in many niche products as a result, thus dominating sales. The company thus accounted for over 95% value share in Ashwagandha, alpha lipoic acid, DHEA and melatonin in 2011, while accounting for over 85% share in Sam-E, chitosan and mineral supplements. The company also dominates co-enzyme Q10 and glucosamine. The company however lost share marginally in 2011 over the previous year, with this due to widening competition in many product areas as chemists/pharmacies and healthfood shops expanded their range of brands and products.

PROSPECTS

  • There is expected to be a widening acceptance for preventative healthcare during the forecast period. Consumers will become increasingly aware of their potential health risks and will take vitamins and dietary supplements in order to prevent health problems, even those set to occur in the distant future. As a result of this trend, calcium supplements is expected to continue to account for the strongest absolute constant value sales growth during the forecast period. This product area is expected to see widening everyday consumption amongst women as they seek to prevent the occurrence of osteoporosis. Calcium supplements is expected to see 6% constant value CAGR during the forecast period and will rise to account for 18% of overall value sales in vitamins and dietary supplements by 2016.

CATEGORY DATA

  • Summary 14 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 85 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 86 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 87 Dietary Supplements by Positioning 2006-2011
  • Table 88 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 89 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 90 Vitamins Brand Shares by Value 2008-2011
  • Table 91 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 92 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 93 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Weight problems are widespread in Saudi Arabia and continued to become more significant during the review period. This was partly due to rich traditional diets and the widening popularity of consumer foodservice. It was also linked to highly sedentary lifestyles. Many move from home to car to work and back again while taking little exercise, while many women spend much of their time at home. The government was also guilty of sending out mixed messages during the review period. While encouraging consumers to lose weight, it banned women-only sports clubs in 2009. By 2011, an estimated 63% of the male population was overweight or obese, while the percentage was even higher among women at 66%.

COMPETITIVE LANDSCAPE

  • Twinlab Corp was the clear leader in weight management in 2011, accounting for 20% value share. This company also saw the strongest growth in value share in the year, rising by almost two percentage points. The company benefits from offering the well-advertised Fibresol brand in meal replacement slimming, with this brand accounting for 49% value share in this product area in 2011. The brand benefits from strong marketing support, wide distribution and affordable prices.

PROSPECTS

  • Weight management is expected to continue to benefit from growing concern about excess weight during the forecast period. Women are becoming more focused on maintaining an attractive appearance and a growing focus on celebrity culture and western lifestyle trends will result in a widening range of women equating beauty with slimness during the forecast period. However, with limited opportunities for women to exercise, many will continue to rely on weight management as they seek to lose weight.

CATEGORY DATA

  • Table 94 Sales of Weight Management: Value 2006-2011
  • Table 95 Sales of Weight Management: % Value Growth 2006-2011
  • Table 96 Weight Management Company Shares 2007-2011
  • Table 97 Weight Management Brand Shares 2008-2011
  • Table 98 Forecast Sales of Weight Management: Value 2011-2016
  • Table 99 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Strong marketing support from leading player Johnson & Johnson continued to drive growth at the end of the review period. From 2009 onwards, this player invested in frequent TV advertising for value-added variants from its Band-Aid range such as Band-Aid Aloe Vera and Band-Aid Liquid Bandage. This advertising not only drove growth for Band-Aid but also for wound care overall, encouraging a growing number of consumers to keep wound care in stock at home in case of emergencies.

COMPETITIVE LANDSCAPE

  • Shares in wound care were heavily shaped by advertising expenditure during the review period. Johnson & Johnson was the clear leader in 2011, accounting for 40% of value and gaining half a percentage point over the previous year. This was thanks to strong advertising support for its Band-Aid range including frequent TV advertising, particularly for value-added variants such as Band-Aid Liquid Bandage in gauze, tape and “other” wound care.

PROSPECTS

  • Consumers are becoming more proactive with regard to their health in Saudi Arabia. This trend is expected to result in first aid kits seeing the strongest constant value growth within wound care during the forecast period, with a constant value CAGR of 6%. A growing number of households are expected to recognise the benefits of keeping first aid kits in stock for themselves and their children. However, growth is expected to be strong partly due to a low sales base, with sales of these products continuing to remain low at just SR500,000 in constant value terms in 2016.

CATEGORY DATA

  • Table 100 Sales of Wound Care by Category: Value 2006-2011
  • Table 101 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 102 Wound Care Company Shares by Value 2007-2011
  • Table 103 Wound Care Brand Shares by Value 2008-2011
  • Table 104 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 105 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Ashwagandha
            • Dandelion
            • Dong Quai
            • Fenugreek
            • Hops
            • Horsetail
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Alpha Lipoic Acid
            • Chitosan
            • DHEA
            • Lecithin
            • Melatonin
            • Yeast
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!